The SR is an intracellular membrane network that is in close contact with the myofibrils and couples with the sarcolemma through transverse tubules (T tubules). The structure of the SR in cardiac muscle is very similar to that described in skeletal muscle (reviewed in Reference 6). As in skeletal muscle, the cardiac SR is composed of two main components: the junctional SR (terminal cisternae) and the longitudinal tubules. However, the structure of the cardiac SR is not as well organized in relation to the T tubule. 
The purpose of this review is to highlight recent advances concerning the regulation of SR gene expression during cardiac hypertrophy and heart failure.
Structure of the Cardiac SR
The SR is an intracellular membrane network that is in close contact with the myofibrils and couples with the sarcolemma through transverse tubules (T tubules). The structure of the SR in cardiac muscle is very similar to that described in skeletal muscle (reviewed in Reference 6). As in skeletal muscle, the cardiac SR is composed of two main components: the junctional SR (terminal cisternae) and the longitudinal tubules. However, the structure of the cardiac SR is not as well organized in relation to the T tubule. 7 There are relatively few T tubules in cardiac muscle, and they are, in general, of large diameter. They are often coupled on only one side to the terminal cisternae, forming a dyad rather than a triad. Interestingly, many of these single couplings or dyads occur between the terminal cisternae and the sarcolemma. In avian ventricular myocytes, 80% of the terminal cisternae (corbular SR) are not associ-ated with T tubules or sarcolemma,7'8 and only 20% of the terminal cisternae form dyads. These observations suggest that in cardiac muscle, excitation-contraction coupling occurs mostly through diffusible signals. It is believed that Ca'+-induced Ca2' release accounts for the opening of the SR Ca'+ release channels in nonjunctional SR of the cardiac muscle.9"10 SR Ca2' Transport Proteins
The major SR proteins controlling Ca'+ release, uptake, and storage have been isolated, and their primary structures have been determined7 (Figure) . The 50 Rohrer and Dillmann54 showed that an increase in Ca2`-ATPase mRNA is detectable as early as 2 hours after triiodothyronine injection into the rat, suggesting that the increase in the Ca24-ATPase mRNA level is associated with enhanced gene transcription. In a recent study, we55 demonstrated that the mRNA levels of SR Ca24-ATPase and ryanodine receptor coordinately increase in hyperthyroid hearts but decrease in hypothyroid hearts. However, a switch from cardiac Ca 2+_ ATPase (SERCA2) to fast-twitch skeletal Ca24-ATPase (SERCA1) did not occur in hyperthyroid hearts.47, 55 We further showed that the Ca24-ATPase protein level increases in parallel with the mRNA, suggesting that the observed changes in mRNA levels are responsible for altered SR function. Interestingly, calsequestrin mRNA levels remain unchanged both in hyperthyroid and hypothyroid hearts. 55 These data demonstrate that in response to thyroid hormone level, the genes encoding SR Ca24 transport proteins are regulated in a discordant manner. Furthermore, these data suggest that alterations in SR functions are primarily linked to the altered expression of genes encoding SR proteins.
Alterations in 2+ transport have also been extensively investigated in the hemodynamically loaded heart. Ca2+ deposition that is observed at the final stages of heart failure. Furthermore, these data also indicate that decreased SR Ca21 uptake is, at least in part, due to the decreased expression of the SR Ca2+-ATPase gene. Heart failure induced by chronic rapid ventricular pacing7879 provides a good model to study the relation between the mechanical properties and Ca 2+ handling in the failing heart. Isometric length-tension studies of these hearts demonstrate that the peak isometric tension is reduced and that the time to peak tension and the time to 90% decline from peak tension are prolonged when compared with the control condition.8081
In the canine pacing model, myosin isozyme composition (100% V3 isoform) and myosin ATPase activity were unaltered,82 suggesting that other mechanisms including Ca2' cycling are responsible for reduced contractility and distensibility. Indeed, simultaneous intracellular Ca 2+ transient measurements using aequorin demonstrate that both the time to peak light (peak [Ca>+]i) and the time to 80% decline from peak light are also prolonged in this model,81 which closely resembles the data from human dilated cardiomyopathic hearts. 83 It was also reported that SR Ca2+-ATPase activity and SR Ca2+ uptake are diminished to half of that of the control muscle.82 Importantly, the decrease in SR Ca'-ATPase activity was positively correlated with left ventricular ejection function, an index of degree of myocardial failure.82 These data suggest that abnormal [Ca2+] handling is one of the important causes of contractile dysfunction that is seen in pacing-induced heart failure. In addition, deficient production of cAMP81 and a defect at the level of the catalytic subunit of adenylate cyclase84 were also observed in these failing hearts, which could modify SR Ca2+ uptake function by affecting the state of phospholamban phosphorylation.
Adriamycin (doxorubicin) is a widely used antineoplastic anthracycline antibiotic, which may provoke severe heart failure (adriamycin cardiomyopathy).85 Disintegrity of cellular components,86 including SR, have been observed, and diverse theories explaining the cause of adriamycin cardiomyopathy have been proposed: free radical production by lipid peroxidation,87 inhibition of oxidative phosphorylation in mitochondria,88 and inhibition of Na+, K+-ATPase. 89 However, abnormal accumulation of intracellular Ca 2+ has been repeatedly reported.90-92 A significant reduction in SR Ca2+-ATPase activity was demonstrated in chronically administered adriamycin cardiomyopathy in dogs.91 It was also demonstrated that adriamycin produces a dose-dependent increase in the open probability of the Ca2' release channel of SR, which will stimulate the release of intracellular Ca21 stores.93 Thus, it is quite likely that adriamycin-induced alteration of the SR Ca 2+ transport function will lead to intracellular Ca 2+ overload, which is closely associated with the pump failure seen in adriamycin cardiomyopathy. However, a detailed study of the expression of SR Ca2' transport Low-output congestive heart failure is a syndrome characterized by both systolic and diastolic dysfunction. 97 The velocity and extent of ventricular contraction and the rate of pressure development are decreased in heart failure.98-101 A number of possible subcellular mechanisms for the observed contractile dysfunction have been explored. These include abnormalities in contractile102-105 and cytoskeletal106 proteins, abnormalities in excitation-contraction coupling,107-109 abnormalities in cardiac metabolism (energy supply),'10"'1 and abnormalities in the signal transduction system.1"2"13
We will focus on the abnormalities in intracellular Ca2+ regulation, especially altered Ca2+ transport and altered expression of genes encoding Ca2+ transport proteins in human failing hearts. Ca 2+ Transport Function in Failing Human Hearts
The SR Ca2+ transport function in failing and normal human hearts has been investigated by use of tissue homogenates or isolated SR vesicles and radiolabeled 45Ca as a tracer for Ca 2+ transport.107'108"114"11The Ca2+ uptake rate measured in crude homogenates of right ventricular biopsy specimens was considerably lower in dilated cardiomyopathy patients (3.3 nmol/mg per minute for the cardiomyopathic group versus 6.5 nmol/mg per minute for the control group). The rate of Ca> uptake showed a modest correlation with several hemodynamic indexes of cardiac performance, ie, pulmonary capillary wedge pressure, cardiac output, and ejection fraction.108 By contrast, Movsesian et al15 have reported that the maximal Ca> uptake rate, the [Ca>] at half-maximal Ca> uptake, and the Hill coefficient are not different between normal and cardiomyopathic hearts. They further showed that the phospholambanmediated stimulation of steady-state Ca> uptake was not significantly different between normal and failing hearts.16 These data were obtained by use of purified SR vesicles from the left ventricle. Discrepancies between these two studies are intriguing and may be partly due to methodological differences, such as the utilization of whole-muscle homogenate versus purified SR vesicles for the Ca> uptake studies. Taken together, these data suggest that the intrinsic Ca2+ uptake activity of SR might not be affected in heart failure but that the amount of Ca> pump per cell is diminished.
The activity of the Ca> release channel in SR (the ryanodine receptor) has also been examined.117-119 Junctional SR membrane vesicles were incorporated into artificial planar phospholipid bilayers, and the activity of a single channel was recorded under voltageclamp conditions.1"7"118 The characteristics of singlechannel behavior from heart failure due to dilated cardiomyopathy, ischemic cardiomyopathy, valvular disease, or congenital heart disease were essentially the same as in normal hearts. To quantify the SR Ca2+ release channel indirectly, tension development in chemically skinned fibers was analyzed.1"9 This study demonstrated that the threshold of Ca> release induced by caffeine (an activator of the Ca> release channel and of the Ca2'-induced Ca> release) was significantly higher in muscles from patients with dilated cardiomyopathy, suggesting that the gating mechanism of the Ca> release channel is impaired.120 These two reports seem contradictory; however, it should be noted that the data generated from single Ca>2 channel measurements may differ from those obtained from the whole muscle (skinned fibers).
Ca2+ This study also showed that a decrease in the ryanodine receptor mRNA levels correlated with the Ca2+-ATPase and phospholamban mRNA levels in failing human hearts, suggesting that these genes are coordinately regulated. 124 This study concluded that the expressions of mRNAs for Ca2' release and of uptake proteins in SR derived from hearts of patients with end-stage heart failure are decreased in parallel, are related to the severity of heart failure, and are independent of the underlying etiology.
Conclusion and Perspectives
The studies reviewed here support a unifying theme: the expression of mRNAs encoding SR Ca2+ transport proteins is altered in a gene-specific manner in cardiac hypertrophy and heart failure both in experimental animal models and in humans. The data are consistent with the hypothesis that abnormal SR Ca2+ handling in hypertrophied and failing hearts is, at least in part, due to altered expression of genes encoding SR Ca2+ transport proteins.
The studies reviewed here do not clarify whether alterations of SR gene expression are etiologic for heart failure or cardiac hypertrophy. Indeed, it is quite likely that these changes are secondary to primary alterations in heart failure or cardiac hypertrophy. However, available evidence reviewed here clearly establishes a correlation between altered Ca21 transport and contractile dysfunction seen in failing hearts of experimental animals and humans. Furthermore, these studies clearly demonstrate that altered expression of SR genes is the major cause of altered Ca2' handling seen in heart failure and cardiac hypertrophy. At the present time, however, the mechanisms regulating the expression of these genes are unknown.
Future studies should be aimed toward establishing a direct cause-and-effect relation between SR dysfunction and its relevance to heart failure. These studies are now possible with newly available tools such as transgenic animal models, in which specific gene alterations may be introduced to alter SR Ca2+ transport function.
